Insiders
3
Bought
$1.9M
Since
+4.2%
- Lawrence Erik Kurzius · Director$1.1M
- Walter M Rosebrough Jr. · Director$542K
- Paul A Keel · Director$250K
Sep 11 – Sep 16 · avg. price $54.18 · insiders up $78K
Health Care stocks insiders are buying
Insider activity across 59 Health Care companies in the last 90 days: $15.9M bought and $1.13B sold on the open market. The sector's median P/E is 24.5.
Recent Health Care cluster buys
Insiders
3
Bought
$3.0M
Since
+6.7%
- Albert Bourla · CEO, Chair$1.0M
- Ronald E Blaylock · Director$999K
- Mortimer J Buckley · Director$960K
Aug 5 – Aug 12 · avg. price $25.77 · insiders up $199K
Insiders
3
Bought
$9.4M
Since
-12.6%
- Michael F Mahoney · CEO, President$9.0M
- Edward J Ludwig · Director$227K
- David C Habiger · Director$150K
Jul 31 – Aug 5 · avg. price $48.25 · insiders down $1.2M
Health Care stocks in Our Picks
All picks →- #3 COO · Cooper Companies, Inc.Score 67/100. 3 insiders bought (cluster); P/E 19.5 vs. sector 24.5
All Health Care stocks we track
Sorted by insider buying in the last 90 days.
| Stock | Bought, 90 days | Sold, 90 days | P/E | 12 months | Insiders |
|---|---|---|---|---|---|
| BSXBoston Scientific | $9.5M | — | 17.2 | -56.4% | Strong buying |
| PFEPfizer | $3.0M | $83K | 36.1 | +11.3% | Strong buying |
| COOCooper Companies (The) | $1.9M | — | 19.5 | -19.5% | Strong buying |
| ELVElevance Health | $1.4M | — | — | +16.6% | Strong buying |
| PODDInsulet Corporation | $162K | — | 25.4 | -56.8% | Strong buying |
| SYKStryker Corporation | $27K | $118M | 29.6 | -23.2% | Net selling |
| CRLCharles River Laboratories | $3K | $25.7M | — | +74.3% | Heavy selling |
| ALGNAlign Technology | — | — | 24.5 | +7.6% | Net selling |
| CVSCVS Health | — | — | 22.9 | +16.1% | Net selling |
| GEHCGE HealthCare | — | — | — | -15.1% | Strong buying |
| HCAHCA Healthcare | — | — | — | +0.4% | Heavy selling |
| HSICHenry Schein | — | — | — | +28.5% | Net selling |
| HUMHumana | — | — | — | +38.4% | Net buying |
| SOLVSolventum | — | — | — | +18.0% | Net buying |
| TECHBio-Techne | — | — | — | +17.6% | Net selling |
| UHSUniversal Health Services | — | — | 7.2 | -14.0% | Net selling |
| VRTXVertex Pharmaceuticals | — | — | — | +24.7% | Heavy selling |
| VTRSViatris | — | — | — | +79.3% | Net selling |
| ZTSZoetis | — | — | — | — | Strong buying |
| AAgilent Technologies | — | $96K | 33.8 | +20.5% | Heavy selling |
| BIIBBiogen | — | $240K | 39.7 | +44.7% | Net selling |
| MDTMedtronic | — | $397K | 21.6 | -8.6% | Heavy selling |
| BMYBristol Myers Squibb | — | $437K | — | +37.9% | Heavy selling |
| UNHUnitedHealth Group | — | $661K | — | +7.7% | Net selling |
| ZBHZimmer Biomet | — | $824K | — | -8.3% | Heavy selling |
| STESteris | — | $957K | — | -12.5% | Heavy selling |
| IDXXIdexx Laboratories | — | $1.2M | — | -17.9% | Heavy selling |
| BDXBecton Dickinson | — | $1.3M | — | +22.4% | Heavy selling |
| RVTYRevvity | — | $1.3M | — | +64.6% | Heavy selling |
| WATWaters Corporation | — | $1.4M | — | +33.2% | Net selling |
| LHLabcorp | — | $3.2M | 25.5 | +14.5% | Heavy selling |
| REGNRegeneron Pharmaceuticals | — | $3.3M | — | +26.8% | Heavy selling |
| AMGNAmgen | — | $4.1M | — | +40.7% | Heavy selling |
| EWEdwards Lifesciences | — | $4.5M | — | +13.0% | Heavy selling |
| CORCencora | — | $4.7M | — | +4.4% | Net selling |
| ISRGIntuitive Surgical | — | $5.0M | — | -10.0% | Heavy selling |
| RMDResMed| | — | $5.3M | 21.4 | -20.7% | Heavy selling |
| WSTWest Pharmaceutical Services | — | $5.4M | — | +39.4% | Net selling |
| MTDMettler Toledo | — | $6.1M | 34.7 | +14.0% | Heavy selling |
| CICigna | — | $6.3M | 11.2 | -7.4% | Net selling |
| DXCMDexcom | — | $6.7M | — | +25.7% | Net selling |
| CNCCentene Corporation | — | $6.9M | — | +71.7% | Net selling |
| MCKMcKesson Corporation | — | $7.1M | 24.5 | +24.8% | Heavy selling |
| ABBVAbbVie | — | $8.2M | — | +19.5% | Heavy selling |
| DGXQuest Diagnostics | — | $8.3M | — | +30.2% | Heavy selling |
| DHRDanaher Corporation | — | $12.7M | — | +2.6% | Heavy selling |
| VEEVVeeva Systems | — | $14.6M | — | -5.4% | Heavy selling |
| GILDGilead Sciences | — | $15.7M | — | +30.1% | Heavy selling |
| LLYLilly (Eli) | — | $16.0M | — | +37.8% | Heavy selling |
| INCYIncyte | — | $18.2M | — | +29.2% | Heavy selling |
| IQVIQVIA | — | $29.9M | — | +26.8% | Heavy selling |
| MRKMerck & Co. | — | $30.0M | 110.7 | +64.5% | Heavy selling |
| DVADaVita | — | $36.5M | 15.1 | +40.8% | Heavy selling |
| ABTAbbott Laboratories | — | $46.9M | — | -24.9% | Strong buying |
| MRNAModerna | — | $49.2M | — | +580.7% | Heavy selling |
| CAHCardinal Health | — | $59.6M | — | +51.8% | Heavy selling |
| TMOThermo Fisher Scientific | — | $61.6M | — | +21.1% | Heavy selling |
| JNJJohnson & Johnson | — | $67.8M | — | +38.5% | Net selling |
| ILMNIllumina, Inc. | — | $436M | — | +170.8% | Net selling |
Other sectors
- Industrials$1.40B bought, 90 days
- Consumer Discretionary$608M bought, 90 days
- Information Technology$14.8M bought, 90 days
- Communication Services$10.3M bought, 90 days
- Financials$9.8M bought, 90 days
- Real Estate$6.3M bought, 90 days
- Consumer Staples$2.3M bought, 90 days
- Utilities$2.0M bought, 90 days
- Materials$1.1M bought, 90 days
- Energy$225K bought, 90 days
Facts from public SEC filings, not investment advice.